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Acinar cell pancreatic carcinoma is a rare solid malignant neoplasm. Recent review of the literature showed occasional cases
with papillary or papillocystic growth patterns, ranging from 2 to 5cm in diameter. We report a large 10cm pancreatic tumor
with papillocystic pathology features involving the pancreatic head. The growth pattern of these tumors could be mistaken for
intraductal papillary mucinous tumors or other pancreatic cystic neoplasms.
1.Introduction
Acinar cell carcinoma of the pancreas is a rare tumor and
account for less than 2% of all pancreatic carcinoma. These
tumors are commonly large well-circumscribed solid and
highly cellular lesions. Recent literature review showed occa-
sional rare cases with papillary or papillocystic growth pat-
tern that can be mistaken for mass forming cystic neoplasms
of the pancreas [1]. Cystic pancreatic tumors represent a
diverse collection of tumors with varied malignant potential
and clinical presentation [2]. The general diﬀerential diag-
nosis includes intraductal papillary mucinous neoplasms
(IPMNS), cystic neuroendocrine tumors, solid pseudopap-
illary tumor and mucinous cystic neoplasms. However, these
tumors carry more indolent and protracted clinical course
than acinar cell carcinoma [3]. The correlation of clinical,
radiographic,histologic,andimmunohistochemical ﬁndings
would be helpful to establish the accurate diagnosis and
management.
2. Case Presentation
A 48-year-old Caucasian male presented in September 2007
with a 10-year history of intermittent epigastric pain. He
reported a recent increase in frequency of the pain, but not
in severity. There were no other gastrointestinal symptoms
suchasweightloss,melena,hematochezia,nausea,vomiting,
dysphagia, change in bowel habits, or jaundice. Serum
amylase, lipase, and tumor markers were normal (CA 19-9:
7KU/L, reference range: <35KU/L; CEA: 1.0µg/L, reference
rage: ≤5µg/L). A combination of imaging studies, includ-
ing transabdominal ultrasound and computed tomography
(CT) of the abdomen and pelvis (Figure 1), showed a large
heterogeneous cystic lesion in the head of the pancreas
measuring 10 × 6.9 × 5.5cm displacing the second segment
of the duodenum laterally. There were no loco regional
lymph nodes, vascular invasion or distant metastases. The
pancreatic duct in the body and tail was only mildly dilated
(4mm), and the biliary tree was not obstructed. Endoscopic
ultrasound (EUS) of the pancreatic mass was performed
utilizing a linear curved array echo endoscope (EG-3630U
Pentax Medical Co, Montvale, NJ). A large heterogeneous
cystic lesion with smooth margins measuring 10 × 7cm
was seen in the head of the pancreas. There were internal
solid components adherent to the wall of the lesion but no
septations. The pancreatic body and tail were normal in
appearances. Fine needle aspiration of both the cystic and
solid components of the lesion was performed using a 22
gauge; 8cm needle (Echotip, Wilson-Cook Medical, Inc.,
Winston-Salem, NC) in 7 passes. Approximately 2cc of thick
viscous ﬂuid was aspirated. Unfortunately, the aspirated cyst
ﬂuid was deemed unsuitable for cyst ﬂuid analysis of CEA2 Journal of Oncology
Figure 1: CT scan showed a large heterogeneous cystic lesion in the
head of the pancreas (arrow).
and amylase levels. Cytology showed malignant cells con-
sistent with pancreatic carcinoma. The patient underwent
pancreaticododudenectomy in November 2007 Pathological
examination showed a large cystic lesion involving the head
of the pancreas with papillary and nodular projections
(Figure 2). The tumor was conﬁned to the pancreas with
no vascular invasion. No tumor was identiﬁed in 6 resected
lymph nodes. Histological section showed a papillary tumor
with ﬁbrovascular cores covered by uniform cells with
granular apical accentuation characteristic of acinar cell
carcinoma (Figure 3). By immunohistochemistry, the tumor
cells were positive for CAM 5.2, amylase, trypsin (Figure 4)
and focally for synaptophysin, and negative for vimentin,
insulin, glucagons, somastostatin, and electron microscopy
conﬁrmed the presence of zymogen granules characteristic
of acinar cell carcinoma. The patient had chemotherapy
postoperatively. He remains alive and well as of July 2009.
3. Discussion
Acinar cell carcinomas of the pancreas are rare tumors and
account for less than 2% of all pancreatic carcinomas. The
disease most often presents in the seventh decade of life, but
canoccuratanyage.Thereisa2 : 1malepredominance.The
presenting symptoms are generally nonspeciﬁc including
abdominal pain and weight loss. In contrast to ductal
adenocarcinoma, jaundice is rare [1]. A minority of patients
may develop a syndrome consisting of lipase hypersecretion
characterized by subcutaneous fat necrosis, polyarthralgia,
and eosinophilia [4]. The long-term survival for acinar cell
carcinoma is poor, however several studies have conﬁrmed
that the clinical course is less aggressive than that of ductal
adenocarcinoma [5]. Macroscopically, acinar cell carcinoma
is typically a large solid and well-circumscribed tumor with
rare cystic degeneration. The literature includes rare cases
of small-sized intraductal and papillary variants of acinar
cell carcinoma [3]. Microscopically, these tumors exhibit
papillary-shaped epithelial projections with well-formed
ﬁbrovascular cores lined by cuboidal cells with acidophlic
apical granules. Immunohistochemically, the tumor cells are
Figure 2: Gross appearance of a large papillocystic pancreatic
lesion.
Figure 3: Photomicrograph showing papillary projections lined by
cuboidal cells.
Figure 4: Immunohistochemical positive staining for trypsin
marker.
positive for trypsin, lipase, and chymotrypsin, which are
speciﬁc markers for acinar cell diﬀerentiation. By electron
microscopy, these tumors exhibit characteristic zymogene
granules. The current case is the ﬁrst large 10cm mass with
a papillocystic pattern of acinar cell carcinoma. Recently,
there have been advances in the classiﬁcation of pancreatic
neoplasia, including the recognition and better characteriza-
tionofintraductalneoplasms.Inadditiontothemicroscopic
dysplastic changes seen with ductal adenocarcinoma, now
referred to as pancreatic intraepithelial neoplasia, there isJournal of Oncology 3
also a group of mass forming intraductal neoplasm, in par-
ticular, intraductal papillary mucinous neoplasms. However
in female patients mucinous cystic neoplasms and solid
pseudopapillery tumors are to be included in the diﬀerential
diagnosis [3]. All lesions exhibit intracystic papillary forma-
tion. Cystic neoplasms of the pancreas represent a diverse
collection of tumors with varied malignant potential and
clinical presentation. They can be predominantly cystic or
can result from cystic degeneration of a solid tumor. Acinar
cell carcinoma with papillocystic pattern can mimic these
tumors, and attention to morphologic details, applications
of immunohistochemistry and electron microscopy can be
useful in establishing the accurate diagnosis. The follow-
up on the few reported cases of papillocystic variant of
acinar cell carcinoma in the literature showed less aggressive
course than the traditional solid variant [3]. This variant
may have diﬀerent biological behavior, but the number
o fr e p o r t e dc a s e si st o os m a l lt od r a wad e ﬁ n i t ec o n -
clusion. The conventional imaging methods that are used
to evaluate cystic lesions of the pancreas are computed
tomography (CT), magnetic resonance imaging (MRI), and
endoscopic retrograde cholangiopancreatography (ERCP).
High-resolution CT, using thin sections with both enhanced
and unenhanced technique, provides detailed information
about cyst structure and may facilitate characterization of
these lesions [6]. MRI has the potential added advantage of
determining communication between the cyst and pancre-
atic duct. ERCP is invasive but is more eﬀective in visualizing
the ductal anatomy. Despite the advancement in cross-
sectional imaging technologies, radiographic diﬀerentiation
of neoplastic from benign pancreatic cystic lesions remains
diﬃcult [7]. EUS on the other hand provides more detailed
images of both pancreatic parenchyma and ductal anatomy
at the same time, and also permits sampling of cyst ﬂuid,
mass lesions, and lymph nodes [7]. for pancreatic carci-
noma, EUS appears to be superior to conventional imaging
including CT, MRI, ERCP, and angiography, particularly
for small masses less than 2-3cm in diameter [8]. It has
been reported in several studies that EUS has a sensitivity
of over 95% for imaging pancreatic tumors 2cm or less in
diameter For pancreatic cystic lesions, a recent prospective,
multicentrestudyof112cystsdiagnosedbysurgicalresection
or positive FNA found a cyst ﬂuid CEA level of 192ng/mL
to be accurate in diﬀerentiating mucinous from nonmuci-
nous pancreatic cysts (sensitivity 75% and speciﬁcity 84%)
[7].
4. Conclusion
We have presented a rare case of papillocystic variant of
acinar cell carcinoma. Acinar cell carcinoma rarely exhibit
papillary or papillocystic pattern, and, therefore, fall into
the challenging diﬀerential diagnosis of papillary and cystic
pancreatic tumors. The correlation of clinical, radiographic,
histological, and immunohistochemical ﬁndings would be
helpful to distinguish such a tumor from other pancre-
atic papillary lesions as they carry diﬀerent prognostic
outcome.
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